BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25449312)

  • 21. Causes of false-negative sentinel node biopsy in patients with breast cancer.
    Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
    Br J Surg; 2013 May; 100(6):775-83. PubMed ID: 23436699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.
    Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ
    Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-Volume Lymph Node Metastases in Endometrial Carcinoma.
    Clinton LK; Kondo J; Carney ME; Tauchi-Nishi P; Terada K; Shimizu D
    Int J Gynecol Cancer; 2017 Jul; 27(6):1165-1170. PubMed ID: 28604450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.
    Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
    Gynecol Oncol; 2018 Mar; 148(3):485-490. PubMed ID: 29290489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study.
    Bogani G; Papadia A; Buda A; Casarin J; Di Donato V; Gasparri ML; Plotti F; Pinelli C; Paderno MC; Lopez S; Perrone AM; Barra F; Guerrisi R; Brusadelli C; Cromi A; Ferrari D; Chiapp V; Signorelli M; Leone Roberti Maggiore U; Ditto A; Palaia I; Ferrero S; De Iaco P; Angioli R; Panici PB; Ghezzi F; Landoni F; Mueller MD; Raspagliesi F
    Gynecol Oncol; 2021 Apr; 161(1):122-129. PubMed ID: 33485641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of sentinel lymph node biopsy in early endometrial cancer: A series of 249 cases.
    Jayot A; Owen C; Bendifallah S; Kolanska K; Boudy AS; Touboul C; Darai E
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():208-215. PubMed ID: 33453523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
    Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
    Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer.
    Sinno AK; Fader AN; Roche KL; Giuntoli RL; Tanner EJ
    Gynecol Oncol; 2014 Aug; 134(2):281-6. PubMed ID: 24882555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
    Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An initial experience of the use of sentinel lymph node biopsy in squamous cell cancer of the vulva].
    Li B; Wu LY; Liu L; Zhang R; Zhang GY; Yu GZ
    Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):364-8. PubMed ID: 19573313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy.
    Buda A; Gasparri ML; Puppo A; Mereu L; De Ponti E; Di Martino G; Novelli A; Tateo S; Muller M; Landoni F; Papadia A
    Gynecol Oncol; 2018 Aug; 150(2):261-266. PubMed ID: 29887483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
    Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
    Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes.
    Khoury-Collado F; Murray MP; Hensley ML; Sonoda Y; Alektiar KM; Levine DA; Leitao MM; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2011 Aug; 122(2):251-4. PubMed ID: 21570109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact.
    Dabbs DJ; Fung M; Johnson R
    Breast J; 2004; 10(3):190-4. PubMed ID: 15125743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2-year experience.
    Di Stefano AB; Acquaviva G; Garozzo G; Barbic M; Cvjeticanin B; Meglic L; Kobal B; Rakar S
    Gynecol Oncol; 2005 Dec; 99(3):671-9. PubMed ID: 16129476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
    Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
    Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer.
    Bjørnholt SM; Sponholtz SE; Mogensen O; Bouchelouche K; Parner ET; Neumann G; Jochumsen KM; Hamid BH; Davidsen MB; Bjørn SF; Dahl K; Jensen PT
    Gynecol Oncol; 2023 Apr; 171():121-128. PubMed ID: 36893488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
    Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.